CM
Crestline Management’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,745
| Closed | -$63.2K | – | 208 |
|
|
2024
Q4 | $63.2K | Buy |
+28,745
| New | +$63.2K | ﹤0.01% | 701 |
|
|
2018
Q3 | – | Sell |
-44,224
| Closed | -$1.73M | – | 175 |
|
|
2018
Q2 | $1.73M | Buy |
+44,224
| New | +$1.73M | 0.18% | 157 |
|
|
2017
Q4 | – | Sell |
-26,350
| Closed | -$1.32M | – | 173 |
|
|
2017
Q3 | $1.32M | Sell |
26,350
-14,616
| -36% | -$733K | 0.18% | 89 |
|
|
2017
Q2 | $1.9M | Buy |
40,966
+13,566
| +50% | +$628K | 0.25% | 45 |
|
|
2017
Q1 | $967K | Buy |
+27,400
| New | +$967K | 0.18% | 55 |
|